Banking giant massively resets Jazz Pharma stock price target
Changes in Wall Street price targets usually arrive in small increments. A few dollars up, a few dollars down, and sometimes a rating left untouched. UBS skipped that script with Jazz Pharmaceuticals (JAZZ). On May 19, UBS analyst Ashwani Verma upgraded Jazz Pharmaceuticals two notches, from …
Changes in Wall Street price targets usually arrive in small increments. A few dollars up, a few dollars down, and sometimes a rating left untouched. UBS skipped that script with Jazz Pharmaceuticals (JAZZ). On May 19, UBS analyst Ashwani Verma upgraded Jazz Pharmaceuticals two notches, from …
Changes in Wall Street price targets usually arrive in small increments. A few dollars up, a few dollars down, and sometimes a rating left untouched. UBS skipped that script with Jazz Pharmaceuticals (JAZZ). On May 19, UBS analyst Ashwani Verma upgraded Jazz Pharmaceuticals two notches, from …
The full story continues on The Street.
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.